Emergence delirium general anesthesia, delirium, children
Conditions
Interventions
Remimazolam 0.15mg/kg at the end of the surgery
Sponsors
Kimura Satoshi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - 2-7 yo - Patients undergoing surgery under general anesthesia - Written consent obtained from the legal guardians or minors' caregivers regarding participation in the study
Exclusion criteria
Exclusion criteria: - Patients eligible for this study from the second occurrence during the study period - Patients with neurological disorders, cardiovascular diseases, or respiratory disorders - Patients undergoing neurosurgery, cardiac surgery, or transplantation surgery - Patients scheduled for thoracotomy or laparotomy - Respiratory tract infection within the past month - Developmental disorders - Preoperative sedative administration - Patients for whom remimazolam administration is not recommended (remimazolam hypersensitivity, glaucoma, severe myasthenia gravis) - Other patients deemed unsuitable for participation in this study by the principal investigator or research collaborator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maximum Pediatric Anesthesia Emergence Delirium (PAED) score | — |
Secondary
| Measure | Time frame |
|---|---|
| The awakening agitation incidence rate, time to awakening (time from anesthesia end to eye opening), postoperative pain (FLACC scale), parental satisfaction (NRS), and the proportion of adverse events. | — |
Contacts
Public ContactSatoshi Kimura
Kyoto University Hospital
Outcome results
None listed